SYNCOM FORMULATIONS (INDIA)
Back to All Ratios
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Return on Equity (ROE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| ROE(%) | 15.69 | 9.30 | 8.48 | 11.83 | 9.32 |
What is the latest Return on Equity (ROE) ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Return on Equity (ROE) |
|---|---|
| Mar2025 | 15.69 |
| Mar2024 | 9.30 |
| Mar2023 | 8.48 |
| Mar2022 | 11.83 |
| Mar2017 | 9.32 |
How is Return on Equity (ROE) of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Return on Equity (ROE) | % Change | |
|---|---|---|---|
| Mar2025 | 15.69 | 68.71 | |
| Mar2024 | 9.3 | 9.67 | |
| Mar2023 | 8.48 | -28.32 | |
| Mar2022 | 11.83 | 26.93 | |
| Mar2017 | 9.32 | - | |
Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Equity (ROE) ratio of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,283.1 Cr | -5.2% | -1.1% | -16% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -5.2% |
-1.1% |
-16% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses